Candel Therapeutics, Inc.CADLNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+74.7%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+74.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
5.3x
Strong expansion
Streak
3 yr
Consecutive growthElevated
PeriodValueYoY Change
20255.76+39.0%
20244.15+24.2%
20233.34+208.6%
20221.08-69.1%
20213.50+162.9%
2020-5.56+65.9%
2019-16.30-